ICARES Medicus, Inc. (TPEX:6612)

Market Cap	4.92B
Revenue (ttm)	1.08B
Net Income (ttm)	94.26M
Shares Out	46.83M
EPS (ttm)	2.00
PE Ratio	47.67
Forward PE	n/a
Dividend	0.27 (0.26%)
Ex-Dividend Date	Aug 22, 2025

Volume	10,170
Average Volume	48,913
Open	105.50
Previous Close	105.00
Day's Range	104.50 - 105.50
52-Week Range	80.45 - 160.91
Beta	0.52
RSI	54.26
Earnings Date	Aug 12, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.